Outpatient Myeloablative Allo-Sct: A Comprehensive Approach Yields Decreased Hospital Utilization and Low TRM

Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2009.234
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Escalating-Dose HLA-mismatched DLI Is Safe for the Treatment of Leukaemia Relapse Following Alemtuzumab-Based Myeloablative Allo-SCT

Bone Marrow Transplantation
TransplantationHematology
2013English

Fatal H1N1 Influenza Infection in an Allo-SCT Recipient

Bone Marrow Transplantation
TransplantationHematology
2010English

Successful Management of Candida Krusei Monoarthritis After Allo-SCT

Bone Marrow Transplantation
TransplantationHematology
2013English

Outcome of Allogeneic (Allo) Stem Cell Transplant (SCT) After Failure of a Prior SCT: A Single Center's Experience

Biology of Blood and Marrow Transplantation
TransplantationHematology
2009English

Leukemia Burden Delays Lymphocyte and Platelet Recovery After Allo-SCT for AML

Bone Marrow Transplantation
TransplantationHematology
2008English

Enteral Nutrition: A First Option for Nutritional Support of Children Following Allo-Sct?

Bone Marrow Transplantation
TransplantationHematology
2012English

Clinical and Biological Predictors of Outcome Following Relapse of CML Post-Allo-SCT

Bone Marrow Transplantation
TransplantationHematology
2014English

Prognostic Factors and Outcome in Relapsed Multiple Myeloma After Nonmyeloablative Allo-Sct: A Single Center Experience

Bone Marrow Transplantation
TransplantationHematology
2010English

Early Allo-SCT for AML With a Complex Aberrant Karyotype—results From a Prospective Pilot Study

Bone Marrow Transplantation
TransplantationHematology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy